Descriptive epidemiology of amyotrophic lateral sclerosis;Epidemiología descriptiva de la esclerosis lateral amiotrófica

Neurologia

Volumn 22, Issue 6, 2007, Pages 368-380

  Matías Guiu, Jordi ^a,b   Galan L ^a   Garcia Ramos R ^a   Vela, A ^a   Guerrero, A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Epidemiology; Incidence rate; Mortality; Prevalence rate

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; DESCRIPTIVE RESEARCH; HUMAN; INCIDENCE; MORTALITY; PREVALENCE; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS;

EID: 34547214278     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (182)

1. Charcot JM, Joffroy A. Deux cas d'atrophie musculaire progressive avec lesions de la substance gris et des faisceaux antero-lateraux de la moelle epineire. Arch Phisiol Neurol Pathol 1869;2:744.
2. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the common neurologic disorders. Neurology 2007;68:326-37.
3. Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992;55:1106-15.
4. Nelson LM. Epidemiology of ALS. Clin Neurosci 1996;3:327-31.
5. Roman GC. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatry 1996;61:131-7.
6. Matías-Guiu J. Neuroepidemiología. Barcelona: Prous Editores, 1992.
7. Kurtzke JF. Epidemiology of amyotrophic lateral sclerosis. Adv Neurol 1982;36:281-302.
8. De Pedro J, Litvan I. Epidemiology of motor neuron disease. En: Anderson DW, editor. Neuroepidemiology, a tribute a Bruce Schomberg. Boca-Raton: CRC Press, 1991; p. 265-96.
9. Beghi E, Logroscino G, Chio A, Hardinan O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population based registries. Biochim Biophys Acta 2006;1762:1150-7.
10. Sene DF, Ndiaye M, Toure K, Ndao AK, Thiam A, Diop AG, et al. Epidemiological and clinical aspects of amyotrophic lateral sclerosis in neurological clinic of Dakar. Dakar Med 2004;49: 167-71.
11. De Castro-Costa CM, Oria RB, Machado-Filho JA, Franco MT, Diniz DL, Giffoni SD, et al. Amyotrophic lateral sclerosis. Clinical analysis of 78 cases from Fortaleza (northeastern Brazil). Arq Neuropsiquiatr 1999;57:761-74.
12. Castro-Costa CM, Oria RB, Vale OC, Arruda JA, Horta WG, D'Almeida JA, et al. Motor neuron disease in the university hospital of Fortaliza (Northeastern Brazil): a clinic-demographic analysis of 87 cases. Arq Neuropsiquiatr 2000;58:986-9.
13. Otero-Siliceo E, Arriada-Mendicoa N, Corona-Vázquez T. Frequency of motor neuron diseases in Mexico City referral center. Rev Invest Clin 1997;49:445-8.
14. Poungvarin N, Viriyavejakul A. Motor neurone disease in Thailand: the clinical aspects of 77 patients. J Med Assoc Thai 1991; 74:181-6.
15. Forbes RB, Colville S, Swingler RJ. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing 2004;33:131-4.
16. Preux P, Druet-Cabanac M, Couratier P, Debrock C, Truong T, Marcharia W, et al. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture models in the Limousin region of France. J Clin Epidemiol 2000;53:1025-9.
17. Coffman CJ, Horner RD, Grambow SC, Lindquist J, for the VA Cooperative Studies Program Project # 500. Estimating the occurrence of amyotrophic lateral sclerosis among Gulf War (1990-1991) veterans using capture-recapture methods. Neuroepidemiology 2005;24:141-50.
18. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial «Clinical limits of amyotrophic lateral sclerosis» workshop contributors. J Neurol Sci 1994;124:96-107.
19. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisted: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
20. Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation in clinical trials in ALS. World Federation of Neurology Committee on Research. J Neurol Sci 1999;169:2-12.
21. Brooks BR. Diagnostic dilemmas in amyotrophic lateral sclerosis. J Neurol Sci 1999;165:S1-9.
22. Zoccolella S, Beghi E, Serlenga L, Logroscino G. Classification of amyotrophic lateral sclerosis casesal presentation in epidemiological studies. Neurol Sci 2005;26:330-3.
23. Sudlow CL, Warlow CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke 1996;27:550-8.
24. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Clinical features of Amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population based study. Arch Neurol 2000;57:1171-6.
25. Beghi E, Balzarini C, Bogliun G, Logroscino G, Manfredi L, Mazzini L, et al. for the Italian ALS Study Group. Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis. Neuroepidemiology 2002;21:265-70.
26. Forbes RB, Colville S, Swingler RJ. Are the El Escorial and Revised El Escorial criteria for ALS reproducible? A study of interobserver agreement. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:135-8.
27. Belsh JM. ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers? Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1 (Suppl. 1):S57-60.
28. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 2000;57:109-13.
29. Ragonese P, Filippini G, Salemi G, Beghi E, Citterio A, D'Alessandro R, et al. Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south in Italy: implications for mortality studies. Neuroepidemiology 2004;23:73-7.
30. Chio A, Magnani C, Oddenino E, Tolardo G, Sehiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health 1992;46:517-8.
31. Chio A, Ciccone G, Calvo A, Vercellino M, Di Vito N, Ghiglione P, et al for the Piemonte and Valle d'Aosta Register for ALS. Validity of hospital morbility records for amyotrophic lateral sclerosis. A population-based study. J Epidemiol 2002;55:723-7.
32. Beghi E, Logroscino G, Micheli A, Millul A, Perini M, Riva R, et al, for Italian ALS Registry Study Group. Vality of hospital discharge diagnosis for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2001;2:99-104.
33. Chancellor AM, Swingler RJ, Fraser H, Clarke JA, Warlow CP. Utility of Scottish morbility and mortality data for epidemiological studies of motor neuron disease. J Epidemiol Community Health 1993;47:116-20.
34. Kurland LT. Epidemiologic investigations of amyotrophic lateral sclerosis 1. preliminary report on geographic distribution with special reference to the Mariana Islands, including ethnical and pathological observations. Neurology 1954;4:438-48.
35. Oyanagi K, Wada M. Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. J Neurol 1999;246:19-27.
36. Mc Geer PL, Schwab C, Mc Geer EG, Haddock RL, Steele JC. Familiar nature and continuing morbility of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam. Neurology 1997;49:400-9.
37. Zhang ZX, Anderson DW, Mantel N, Roman GC. Motor neuron disease on Guam: geographic and familiar occurrence, 1956-1985. Acta Neurol Scand 1996;94:51-9.
38. Chen X, Xia Y, Gresham LS, Molgaard CA, Thomas RG, Galasko D, et al. Apo E and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, Guam. Neurology 1996;47:779-84.
39. Yase Y, Yoshida S, Kihira T, Wakayama I, Komoto J. Kii ALS dementia. Neuropathology 2001;21:105-9.
40. Gajdusek DC, Salazar AM. Amyotrophic lateral sclerosis and parkinsonism syndromes in high incidence among Auyu and Jakai of West New Guinea. Neurology 1982;32:155-9.
41. Kiloh LG, Lethlean AK, Morgan G, Cawte JE, Harris M. An endemic neurological disorder in tribal australian aborigines. J Neurol Neurosurg Psychiatry 1980;43:661-8.
42. Koerner DR. Amyotrophic lateral sclerosis on Guam. A clinical study and review of the literature. Ann Intern Med 1952;37: 1204-20.
43. Arnold A, Edgren DC, Pallardino VS. Amyotrophic lateral sclerosis. Fifty cases observed on Guam. J Nerv Ment Dis 1953; 117:135-9.
44. Tillema S, Wijnberg CJ. Endemic amyotrophic lateral sclerosis on Guam: epidemiological data: a preliminary report. Doc Geogr Trop 1953;5:366-70.
45. Hirano A, Kurland LT, Krooth RS, Lessell S. Parkinsonism-dementia complex and endemic diseases on the island of Guam I. Clinical Features. Brain 1961;84:642-61.
46. Hirano A, Malamud L, Kurland LT, Parkinsonism-dementia complex and endemic disease on the island of Guam. II. Pathological features. Brain 1961;84:662-70.
47. Plato CC, Cruz MT, Kurland LT. Amyotrophic lateral sclerosis/ parkinsonism-dementia complex of Guam: further genetic investigations. Am J Hum Genet 1969;21:133-41.
48. Bailey-Wilson JE, Plato CC, Elston TS, Garruto RM. Potential role of an additive genetic component in the cause of amyotrophic lateral sclerosis and parkinsonism-dementia in the western pacific. Am J Med Genet 1993;45:68-76.
49. Plato CC, Reed DM, Elizan TS, Kurland LT. Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. IV. Familiar and genetic investigations. Am J Hum Genet 1967;19: 617-32.
50. Reed DM, Torres JM, Brody JA. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam 1945-1972. Il Familiar and genetic studies. Am J Epidemiol 1975;101:302-10.
51. Plato CC, Garruto RM, Fox KM, Gadjusek DC. Amyotrophic and parkinsonism-dementia on Guam: a 25 year prospective case-control study. Am J Epidemiol 1986;124:643-56.
52. Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, et al. ALS and PDC of Guam. Forty-year follow up. Neurology 2002;58:765-3.
53. Reed D, Labarthe D, Chen KM, Stallones R. A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota. Am J Epidemiol 1987;125:92-100.
54. Galasko D, Salmon D, Craig UK, Widerholt W. The clinical spectrum of Guam ALS and Parkinson-dementia complex: 1997-1999. Ann NY Acad Sci 2000;920:120-5.
55. Matsumoto S, Hirano A, Goto S. Spinal cord neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia complex: an immunohistochemical study. Neurology 1990;40:975-9.
56. Garruto M. A commentary on neuronal degeneration and cell death Guam ALS and PD: an evolutionary process of understanding. Curr Alzheimer Res 2006;3:397-401.
57. Rodgers-Johnson P, Garruto RM, Yanagihara R, Chen KM, Gajdusek DC, Gibbs CJ Jr, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30 years evaluation of clinical and neuropathological trends. Neurology 1986;36:7-13.
58. Galasko D, Salmon DP, Craig UK, Thai LJ, Gamst A, Craig UK, et al. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology 2002;58:90-7.
59. Widerholt WC. Neuroepidemiological research initiatives on Guam: past and present. Neuroepidemiology 1999;18:279-91.
60. Garruto RM, Yanagihara R, Gajdusek DC. Disapperance of high incidence ALS and PDC on Guam. Neurology 1985;35:193-8.
61. Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003;157:149-57.
62. Yanagihara RT, Garruto RM, Gajdusek DC. Epidemiological surveillance of amyotrophic lateral sclerosis and parkinsonism-dementia complex in the common-wealth of the Northern Mariana Islands. Ann Neurol 1983;13:79-86.
63. Chen K-M, Makifuchi T, Garruto RM, Gaddusek DC. Parkinsonism-dementia in a filipino-emigrant: a clinicopathological case report. Neurology 1982;32:1221-6.
64. Oyanagi K. The nature of the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam and magnesium deficiency. Parkinsonism Relat Disord 2005;11:S17-23.
65. Spencer PS, Nunn PB, Hugon J. Guam amyotrophic lateral sclerosis-parkinsonism dementia linked to a plant excitant neurotoxin. Science 1987;237:517-22.
66. Duncan W, Steele J, Kopsin I, Stamford P. 2-amino-3-(methylamino)- propanoic acid (BMAA) in cycad flour: an unlike cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology 1990;40:767-72.
67. Cox P, Sacks O. Cicaid neurotoxins, comsumption of flying foxex and ALS/PDC disease in Guam. Neurology 2002;58:956-9.
68. Banack S, Cox P. Biomagnification of cycaid neurotoxins in flyng foxes. Neurology 2002;61:387-9.
69. Cox P, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. PNAS 2003;23:13380-3.
70. Ince PG, Codd GA. Return to cycaid hypothesis-does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PCD) of Guam have new implications for global health? Neuropathol Appl Neurobiol 2005;31:345-53.
71. Cox PA, Banack S, Murch S, Sacks O. Return to cycaid hypothesis-does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PCD) of Guam have new implications for global health? Neuropathol Appl Neurobiol 2006;32:679-82.
72. Miura K. Uber die amyotrophische lateral sclerosis. Nihon Shinkeigaku Zasshi 1902;1:1-15.
73. Kimura K, Yase Y, Higashi Y. Study on amyotrophic lateral sclerosis. Epidemiological and genetic studies on amyotrophic lateral sclerosis and its allied diseases in Kii pensinsula, Japan. Psychiatr Neurol Japn 1963;65:31-8.
74. Yase Y. Neurologic disease in the western Pacific islands with a report of the focus of amyotrophic lateral sclerosis found in Kii Pensinsula, Japan. Am Trop Med Hyg 1970;19:155-66.
75. Shikari H, Yase Y. Amyotrohic lateral sclerosis in Japan. En: Vinken PJ, Bruyn GW, editores. Handbook of Clinical Neurology 22, New York: American Elsevier Publishing, 1975; p. 353-419.
76. Uebayashi Y, Matsumoto N, Yase Y. Epidemiological study of motor neuron disease (MND) in Kii Peninsula of Japan. A ten year follow up study of the mortality rate of MND. Rinsho Schinkeigaku 1975;15:443-9.
77. Yoshida S, Uebayashi Y, Kihira T, Kohmoto J, Wakayama I, Tagushi S, et al. Epidemiology of motor neuron disease in the Kii Peninsula of Japan 1989-93. Active or disappering focus? J Neurol Sci 1998;155:146-55.
78. Kuzuhara S. Familiar ALS-parkinsonism-dementia in the Kii peninsula. Neurol Med 1999;50:137-45.
79. Yase Y, Yoshida S, Kihira T, Wakayama I, Komoto J. Kii-ALS dementia. Neuropathology 2001;21:105-9.
80. Hornabrook RW. Amyotrophic lateral sclerosis in New Guinea. En: Vinken PJ, Bruyn GW, editores. Handbook of Clinical Neurology 22, part II. New York: American Elsevier Publishing Co Inc, 1975; p. 349-51.
81. Neuman NM, Gajdusek DC, Zigas V. Neuropathologic findings in exotic neurologic disorders among natives of the highlands of New Guinea. J Neuropathol. Exp Neurol 1964;23:486-507.
82. Gajdusek DC. Motor neurone disease in natives of New Guinea. N Engl J Med 1963;268:474-6.
83. Hornabrook RW. The auyuna Heas nooders. Papua N Guinea Med J 1970;13:90-2.
84. Cawte J. Emic account of a mystery illness: the Groot-Eyland Syndrome. Aust NLZ Psychiatry 1984;18:179-87.
85. Stauber JL, Florence TM. Manganese scalp hair: problems of exogenous manganese and implication for manganese motoring in Groote Eylandt aborigenes. Sci Total Environ 1989; 83:85-98.
86. Cawte J, Kiborn C, Florence M. Motor neurone disease of the Western Pacific: do the foci extend to Australia. Neurotoxicology 1989;10:263-70.
87. Cawte J. Florence M. Environmental source of manganese on Groote Eylandt, northern Australia. Lancet 1987;1:1484.
88. Stauber JL, Florence TM, Webster WS. The use of scalp hair to monitor manganese in aborigenes from Groote Eylandt. Neurotoxicology 1987;431-5.
89. Donalson J. Manganese Madness. Clues to the aetiology of human brain emerges from a geological anomaly. www.medical-geology.org.
90. Caparros-Lefebre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, et al. Guadaloupean parkinsonism: a cluster of progressive supranuclear palsy, like tautopathy. Brain 2002; 125:801-11.
91. Caparros-Lefevre D, Elbaz A, and the Caribbean Parkinsonism Study Group. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case control study. Lancet 1994;354:281-6.
92. Kotake Y, Yoshida M, Ogawa M, Tasaki Y, Hirobi M, Ohta S. Chronic administration of 1- benzyl 1-2-2-4-tetrahidroisoquinoline, an endogenous amine in the brain induces parkinsonism in a primate. Neurosci Lett 1996;217:69-71.
93. Lannuzel A, Michel PP, Höllenger CU, Champy P, Jousset A, Medja F, et al. The mitocondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Neuroscience 2003;121:287-96.
94. Steele JC, Caparros-Lefebre D, Lee AS, Sacks O. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and guadaloupean parkinsonism. Parkinsonism Relat Disord 2002;9:39-54.
95. Mitchell JD, Gibson HN, Gatrell AC. Amyotrophic lateral sclerosis in Lancashire and south Cumbria, England, 1976-1986. A geographical study. Arch Neurol 1990;47:875-80.
96. Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. J Neurol Neurosurg Psychiatry 1998;65:842-7.
97. Gunnarsson LG, Lygner PE, Veiga-Cabo J, de Pedro-Cuesta J. An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984. Neuroepidemiology 1996;15:142-52.
98. Taylor JA, Davis JP. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. J Clin Epidemiol 1989;42:569-75.
99. Corcia P, Jafari-Schluep HF, Lardillier D, Mazyad H, Giraud P, Clavelou P, et al. A clustering of conjugal amyotrophic lateral sclerosis in southeastern France. Arch Neurol 2003;60:553-7.
100. Cornblath DR, Kurland LT, Boylan KB, Morrison L, Radhakrishnan K, Montgomery M. Conjugal amyotrophic lateral sclerosis: report of a young married couple. Neurology 1993;43:2378-80.
101. Poloni M, Micheli A, Facchetti D, Mai R, Ceriani F, Cattalini C. Conjugal amyotrophic lateral sclerosis: toxic clustering or change? Ital J Neurol Sci 1997;18:109-12.
102. Rachele MG, Mascia V, Tacconi P, Dessi N, Marrosu F, Giagheddu M. Conjugal amyotrophic lateral sclerosis: a report on a couple from Sardinia, Italia. Ital J Neurol Sci 1998;19:97-100.
103. Cadilhac J, Billiard M. Conjugal amyotrophic lateral sclerosis: a report on a two couples from southern France. Neurology 1994;44(3 Pt 1):547-8.
104. Betemps EJ, Buncher CR. Birthplace as a risk factor in motor neurone disease and Parkinson's disease. Int J Epidemiol 1993; 22:898-904.
105. Dean G, Brady R, McLoughlin H. Motor neurone disease and multiple sclerosis among immigrants to Britain. Br J Prev Soc Med 1977;31:141-7.
106. Elian M, Dean G. Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean and east and west Africa. J. Neurol Neurosurg Psychiatry 1993;56:454-7.
107. Gross-Paju K, Oopik M, Luus S, Kalbe I, Kaasik AE. The risk of motor neurone disease and multiple sclerosis is diferent in estonians and russians. Data from South Estonia. Eur J Neurol 1999;6:187-93.
108. Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005;25:114-9.
109. Stallones L, Kasarskis EJ, Stipanowich C, Snider G. Secular trends in mortality rates from motor neuron disease in Kentucky 1964-1984. Neuroepidemiology 1989;8:68-78.
110. Neilson S, Robinson I, Hunter M. Longitudinal Gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimates of susceptibility in the general population. Mech Ageing Dev 1992;64:201-16.
111. Neilson S, Robinson I, Hunter M. Static and dinamic models of interdisease competition: past and projected mortality from amyotrophic lateral sclerosis and multiple sclerosis. Mech Ageing Dev 1993;66:223-41.
112. Mueller LD, Rose MR. Evolutionary theory predicts late-life mortality plateaus. Proc Natl Acad Sci 1996;93:15249-53.
113. Hirsch HR. Can an improved environment cause maximun lifespan to decrease? Comments on lifespan criteria and longitudinal Gompertzian analysis. Exp Gerontol 1994;29:119-37.
114. Chio A, Magnani C, Schiffer D. Gompertzian analysis of amyotrophic lateral sclerosis mortality in Italy, 1957-1987: application to birth cohorts. Neuroepidemiology 1995;14:268-77.
115. Neilson S, Robinson I. Reinterpreting mortality statistics: some uses of Gompertzian analysis in epidemiological research. J Clin Epidemiol 1993;46:1063-9.
116. Neilson S, Robinson I. Cross-sectional Gompertzian analysis: the developme nt of a Gompert mortality ratio (GMR) and its applicability. Mech Ageing Dev 1993;68:137-49.
117. Riggs JE. Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the US, 1977-1986: evidence for an inherently susceptible population subset. Mech Ageing Dev 1990;55:207-20.
118. Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis in France 1968-1990: increased life expectancy and inter-disease competition as an explication. J Neurol 1994;241:448-55.
119. Malamud N, Hirano A, Kurland LT. Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Special reference to the occurrence of neurofibrillary changes. Arch Neurol 1961; 5:401-15.
120. Hirano A, Malamud N, Elisan T, Kurland LT. Amyotrophic lateral sclerosis and parkinson-dementia complex on Guam. Further pathological studies. Arch Neurol 1966;15:35-51.
121. Huber S, Henn V. Unchanged incidence and prevalence of amyotrophic lateral sclerosis in the canton of Zurich. Schweiz Arch Neurol Psyehiatr 1995;146:52-4.
122. Kahana E, Alter M, Feldman S. Amyotrophic lateral sclerosis: a population study. J Neurol 1976 14:212:205-13.
123. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504-9.
124. Alcaz S, Jarebinski M, Pekmezovic T, Marinkovic Z, Apostolski S. Amyotrophic lateral sclerosis in a defined population in Belgrade-an epidemiologic study. Vojnosanit Pregl 1997;54:19-26.
125. Alcaz S, Jarebinski M, Pekmezovic T, Stevic-Marinkovic Z, Pavlovic S, Apostolski S. Epidemiological and clinical characteristic of ALS in Belgrade. Acta Neurol Scand 1996;94:264-8.
126. Tysnes OB, Vollset SE, Aarli JA. Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand 1991;83:280-5.
127. Tysnes OB. Amyotrophic lateral sclerosis. Ocurrence and prognosis. Tidsskr Nor Laegeforen 1991;111:2634-6.
128. Bettoni L, Bazzani M, Bortone E, Dascola I, Pisani E, Mancia D. Steadiness of amyotrophic lateral sclerosis in the province of Parma, Italy, 1960-1990. Acta Neurol Scand 1994;90:276-80.
129. Juvarra G, Bettoni L, Bortone E, Garavelli A, Montanari E, Rocca M. Amyotrophic lateral sclerosis in the province of Parma. Italy: a clinical and epidemiological study in the period 1960-1980. Ital J Neurol Sci 1983;4:473-8.
130. Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology 2003;60:683-9.
131. De Domenico P, Malara CE, Marabello L, Puglisi RM, Meneghini F, Serra S, et al. Amyotrophic lateral sclerosis: an epidemiological study in the province of Messina, Italy, 1976-1985. Neuroepidemiology 1988;7:152-8.
132. Bracco L, Antuono P, Amaducci L. Study of epidemiological and etiological factors of amyotrophic lateral sclerosis in the province of Florence, Italy. Acta Neurol Scand 1979;60:112-24.
133. Scarpa M, Colombo A, Panzetti P, Sorgato P. Epidemiology of amyotrophic lateral sclerosis in the province of Modena, Italy. Influence of environmental exposure to lead. Acta Neurol Scand 1988;77:456-60.
134. Salemi G, Fierro B, Arcara A, Cassata M, Castiglione MG, Savettieri G. Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study. Ital J Neurol Sci 1989;10:505-9.
135. Rosati G, Pinna L, Granieri E, Aiello I, Tola R, Agnetti V, et al. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977;55:231-44.
136. Giagheddu M, Puggioni G, Masala C, Biancu F, Pirari G, Piras MR, et al. Epidemiological study of amyotrophic lateral sclerosis in Sardinia, Italy. Acta Neurol Scand 1983;68:394-404.
137. Giagheddu M, Mascia V, Cannas A, Pirastru MI, Sanna F, Rachele MG, et al. Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiological study. Acta Neurol Scand 1993;87:446-54.
138. PARALS. Incidence of ALS in Italy: evidence for a frequency in Western countries. Neurology 2001;56:239-44.
139. Chio A, Cucatto A, Calvo A, Terreni AA, Magnani C, Schiffer D. Amyotrophic lateral sclerosis among the migrant population to Piemonte, nortwestern Italy. J Neurol 1999;246:175-80.
140. Govoni V, Granieri E, Capone J, Manconi M, Casetta I. Incidence of amyotrophic lateral sclerosis in the local health district of Ferrara, Italy, 1964-1998. Neuroepidemiology 2003;22: 229-34.
141. Guidetti D, Bondavalli M, Sabadini R, Marcello N, Vinceti M, Cavalletti S, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology 1996;15: 301-12.
142. Leone M, Chio A, Mortara P, Rosso MG, Schiffer D. Motor neuron disease in the province of Turin, 1971-1980. Acta Neurol Scand 1983;68:316-27.
143. Beghi E, Millul A, Micheli A, Vitelli E, Longroscino G. Incidence of ALS in Lombardy, Italy. Neurology 2007;68:141-5.
144. Murros K, Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland; an epidemiological study. Acta Neurol Scand 1983;67:41-7.
145. Hojer-Pedersen E, Christensen PB, Jensen NB. Incidence and prevalence of motor neuron disease in two danish counties. Neuroepidemiology 1989;8:151-9.
146. Gross-Paju K, Oopik M, Luus SM, Kalbe I, Puksa L, Lepik T, et al. Motor neuron disease in South Estonia. Diagnosis and incidence. Acta Neurol Scand 1998;98:22-8.
147. Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983;68:20-9.
148. Gunnarsson LG, Lygner PE, Veiga-Cabo J, de Pedro-Cuesta J. An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984. Neuroepidemiology 1996; 15:142-52.
149. The Scottish Motor Neuron Disease Register. A prospective study of adult onset motor neuron disease in Scotlant, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992;55:536-41.
150. López-Vega JM, Calleja J, Combarros O, Polo JM, Berciano J. Motor neuron disease in Cantabria. Acta Neurol Scand 1988; 77:1-5.
151. Mochecka-Thoelke A. Clinical pattern and epidemiological analysis of amyotrophic lateral sclerosis in the Lodz Region in 1980-1986. Neurol Neurochir Pol 1994;28:189-94.
152. Potemkowski A, Honczarenko K, Fabian A. Clinical course and epidemiological analysis of amyotrophic lateral sclerosis in Szczecin in 1986-1995. Neurol Neurochir Porl 1999;33:71-8.
153. Argyriou AA, Polychronopoulos P, Papapetropoulos S, Ellul J, Andriopoulos I, Katsoulas G, et al. Clinical and epidemiological features of motor neuron disease in south-western Greece. Acta Neurol Scand 2005;111:108-13.
154. Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol 1991;48:589-93.
155. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996;47:571-3.
156. Zack M, Levitt L, Schoemberg BS. Motor neuron disease in Lehigh County, Pennsylvania: an epidemiological study. J Chronic Dis 1977;30:813-8.
157. Juergens SM, Kurland LT, Okazaki H, Mulder DW. ALS in Rochester, Minnesota, 1925-1977. Neurology 1980;30:463-70.
158. Olivares L, San Esteban E, Alter M. Mexican resistence to amyotrophic lateral sclerosis. Arch Neurol 1972;27:397-402.
159. Okumura H, Moriwaka F, Tashiro K, Hamada T, Matsumoto A, Matsumoto H, et al. Epidemiological study of motor neuron disease in Hokkaido island- its incidence, prevalence and regional distributions-ALS Study Group. No to Schinkei 1992; 44:727-32.
160. Kihira T, Yoshida S, Hironishi M, Miwa H, Okamato K, Kondo T. Changes in the incidence of amyotrophic lateral sclerosis in Wakayama, Japan. Amyotroph Lateral Scler Motor Neuron Disord 2005;6:155-63.
161. Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology 1996;15:239-45.
162. Fong GC, Cheng TS, Lam K, Cheng WK, Mok KY, Cheung CM, et al. An epidemiological study of motor neuron disease in Hong Kong. Amyotroph Lateral Scler Motor Neuron Disord 2005; 6:164-8.
163. Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Descriptive epidemiology of motor neuron disease in Benghazy, Libyia. Neuroepidemiology 1986;5:47-54.
164. Brewis M, Poskanzer DC, Rolland C, Miller H. Neurological diseases in an English City. Acta Neurol Scand 1966;42(Suppl.): 60-6.
165. Jokelainen M. Amyotrophic lateral sclerosis in Finland I: an epidemiological study. Acta Neurol Scand 1977;56:103-85.
166. Jokelainen M. Amyotrophic lateral sclerosis in Finland II: clinical characteristics. Acta Neurol Scand 1977;56:194-204.
167. Gunnarsson LG, Palm R. Motor neuron disease and heavy manual labor: an epidemiological survey of Varmland County. Sweden Neuroepidemiology 1984;3:195-8.
168. Svenson LW, Cwik VA, Martin WR. The prevalence of motor neurone disease in the province of Alberta. Can J Neurol Sci 1999;26:119-22.
169. Kahana E, Alter M, Feldman S. Amyotrophic lateral sclerosis: a population study. J Neurol 1976 14;212:205-13.
170. Durrleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology 1989;39:768-73.
171. Chio A, Magnani C, Schiffer D. Amyotrophic lateral sclerosis mortality, 1958 to 1987: a cross-sectional and cohort study. Neurology 1993;43:927-30.
172. Guidetti D, Bondavalli M, Sabadini R, Marcello N, Vinceti M, Cavalletti S, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology 1996;15: 301-12.
173. Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry 1983;46:197-205.
174. Veiga-Cabo J, Almazán-Isla J, Sendra-Gutiérrez JM, de Pedro-Cuesta J. Differential features of motor neuron disease mortality in Spain. Int J Epidemiol 1997;26:1024-32.
175. Neilson S, Robinson I, de Pedro-Cuesta J, Veiga-Cabo J. Decline and rise of mortality from motor neuron disease in Spain, 1960-1989: demographic, environmental and competitive influences. Neuroepidemiology 1996;15:180-91.
176. Neilson S, Robinson I, Nymoen EH. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci 1994; 122:148-54.
177. Jokelainen M. The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients. J Neurol Sci 1976;29:55-63.
178. Maasilta P, Jokelainen M, Loytonen M, Sabel CE, Gatrell AC. Mortality from amyotrophic lateral sclerosis in Finland, 1986-1995. Acta Neurol Scand 2001;104:232-5.
179. Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway. Neurology 2000;55: 1262-3.
180. Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001. J Epidemiol 2005;15:20-3.
181. Leone M, Chandra V, Schoenberg BS. Mortality neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology 1987;37:1339-43.
182. Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology 2005;25:144-52.